Navigation Links
GenVec Reports First Quarter 2011 Financial Results
Date:5/9/2011

GAITHERSBURG, Md., May 9, 2011 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVCD) today announced its financial results for the first quarter ended March 31, 2011.  

GenVec reported a net loss of $2.2 million ($0.17 per share) for the first quarter of 2011, compared to a net loss of $4.7 million ($0.39 per share) in the comparable quarter of 2010.  Per share data reflect the reverse stock split that took effect on April 19, 2011.

Revenue for the first quarter increased 80% to $5.3 million from $2.9 million in the same period last year.  The increase for the three-month period ended March 31, 2011 is primarily due to increased revenue associated with our hearing program with Novartis of $2.7 million.  The higher revenue for the hearing program is the result of the increased work scope and effort in 2011.  Partially offsetting this increase is decreased revenue associated with our HIV program of $0.6 million due to decreased work scope.  

Operating expenses for the first quarter of 2011 decreased 2% to $7.5 million from $7.7 million in the same period last year. Research and development expenses for the three-month period ended March 31, 2011 decreased 3% to $5.6 million from $5.7 million in 2010.   The decrease is primarily due to lower personnel costs due mainly to the termination of our TNFerade trial.  These decreases are partially offset by increased expenses under our hearing programs.  

General and administrative expenses for the three-month period ended March 31, 2011 remained at approximately $1.9 million in each period. During the three-month period ended March 31, 2011 we experienced lower professional costs, offset by higher personnel costs.  

GenVec ended the first quarter of 2011 with $33.1 million in cash, cash equivalents, and investments.  

2011 Guidance"Our financial performance in the first quarter reflects our strategy of moving our technology and prod
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
2. GenVec Expands Contract Supporting Malaria Vaccine Program
3. GenVec Reports Second Quarter 2009 Financial Results
4. GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development
5. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
6. GenVec Announces Third Quarter 2009 Results Conference Call
7. GenVec Reports Third Quarter 2009 Financial Results
8. Merriman Curhan Ford Acted as Placement Agent in GenVecs $28 Million Registered Offering
9. GenVec to Present at the 13th Annual BIO CEO & Investor Conference
10. GenVec To Host Fourth Quarter and Year-End 2010 Earnings Call and Webcast
11. GenVec, Inc. Announces Effectiveness of Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)...  ViveBio, LLC a leading provider of products ... announced today that it has signed a distribution ... Knoxville, Tennessee to distribute ... United States . ViveST is the first ... biological specimen transport systems.  The technology enables easy, ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
(Date:8/26/2014)... N.Y. , Aug. 26, 2014 Albany ... today that William S. Marth , President and ... Morgan Stanley Global Healthcare Conference on Monday, September 8, ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:8/26/2014)... Aug. 26, 2014 /PRNewswire-iReach/ -- The crowdfunding campaign for ... full effect on the popular crowdfunding platform Kickstarter. Backers ... for the biofeedback belt. The $75,000 funding goal for ... distribute the product. Photo - http://photos.prnewswire.com/prnh/20140825/139254 ... worn on the lower back that silently vibrates if ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3PosturePulse, A Biofeedback Posture-Improving Belt, Improves Posture While Sitting or Standing 2
... steps toward putting quantum computers into real practice sending ... and transmitting the signal to a second, distant qubit ... Yale. The accomplishments are reported in sequential issues of Nature ... highlighted as the cover along with complementary work from a ...
... 3% over Fiscal 2006 to $27.5 million - ... dollars unless otherwise noted), BELLEVILLE, ON, Sept. 26 ... technology-driven Canadian,biopharmaceutical company, today announced financial results for its ... announcements of the first shipment and commercial usage of,our ...
... Sept. 26 Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ... in New York City on Thursday, October 4, 2007,from ... Westin New York at Times,Square, on 270 West 43rd ... C. Quay, M.D., Ph.D., Chairman, President and,Chief Executive Officer ...
Cached Biology Technology:Yale scientists make 2 giant steps in advancement of quantum computing 2Yale scientists make 2 giant steps in advancement of quantum computing 3Bioniche Reports Fiscal 2007 Year-End Results 2Bioniche Reports Fiscal 2007 Year-End Results 3Bioniche Reports Fiscal 2007 Year-End Results 4Bioniche Reports Fiscal 2007 Year-End Results 5Bioniche Reports Fiscal 2007 Year-End Results 6Bioniche Reports Fiscal 2007 Year-End Results 7Bioniche Reports Fiscal 2007 Year-End Results 8Bioniche Reports Fiscal 2007 Year-End Results 9Bioniche Reports Fiscal 2007 Year-End Results 10Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3
(Date:8/25/2014)... Mo. Boron deficiency is one of the most ... eastern half of the United States are plagued by ... are required to supplement their soil with boron; however, ... plants utilize the essential nutrient. Now, researchers at the ... integral role in development and reproduction in corn plants. ...
(Date:8/25/2014)... certain type of biomolecule built like a nano-Christmas tree. ... sugary ornaments. , It,s those ornaments that get all ... glycoconjugate,s lowly "tree" basically holds the sugars in place ... other molecules. , Now a chemist at Michigan Technological ... a good deal more than a simple prop. , ...
(Date:8/25/2014)... Services of Western Australia, a bushfire ADVICE remains for people ... Broome, and Cape Leveque Road approximately 40 kilometres north of ... threat to lives or homes but there is a lot ... of fires burning in the area on both sides of ... are also burning on the eastern side of Cape Leveque ...
Breaking Biology News(10 mins):Researchers find boron facilitates stem cell growth and development in corn 2
... (Oct. 19, 2008) Researchers have discovered a mechanism for ... childhood tumor. The tumors, which are made ... of children of European descent, with girls more frequently afflicted ... often as a single, blood-red lump on the head or ...
... The first reports of the successful reprogramming of adult ... which by all appearances looked and acted liked embryonic stem ... inefficient: Only one out of 10,000 cells could be persuaded ... researchers led by Juan Carlos Izpisa Belmonte at the Salk ...
... helps celebrate the season. While overindulging leads to calorie ... chocolate can actually make one feel and even look ... of CHOCOLATEA HEALTHY PASSION (Prometheus Books, $19.98), can explain ... its history, culture, sensory pleasures and more. , Science ...
Cached Biology News:Researchers identify Achilles heel of common childhood tumor 2Salk researchers successfully reprogram keratinocytes attached to a single hair 2Salk researchers successfully reprogram keratinocytes attached to a single hair 3Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 2Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 3
Troponin I Immunogen: Full length native protein (purified) (Human). Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
Troponin I (22B11)...
... freezers , Ultima II Series ... storage, Ultima II represents the finest, most ... purpose and blood bank configurations, each Ultima ... control system with built-in voltage boost and ...
Biology Products: